New Key Statistics Module, Z-Score and F-Score
NAS:LIPO Key Ratios
Market Cap $ M | 4.94 |
Enterprise Value $ M | 2.99 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.80 |
Price/Sales | 9.92 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.75 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.63 |
EV-to-EBITDA | -0.63 |
PEG | -- |
Shares Outstanding M | 7.61 |
Net Margin (%) | -1,054.22 |
Operating Margin % | -1,084.44 |
Pre-tax Margin (%) | -1,054.22 |
Quick Ratio | 5.45 |
Current Ratio | 5.45 |
ROA % (ttm) | -134.31 |
ROE % (ttm) | -159.54 |
ROIC % (ttm) | -1,437.83 |
Dividend Yield % | -- |
Altman Z-Score | -3.86 |
LIPO Number of Guru Trades
LIPO Volume of Guru Trades
Gurus Latest Trades with NAS:LIPO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LIPO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lipella Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LIPO
Total 0- 1